Article | March 14, 2017

5 Ways Electronic Data Capture (EDC) Reports Can Protect Clinical Research Timelines

Source: Medrio
5 Ways Electronic Data Capture (EDC) Reports Can Protect Clinical Research Timelines

The adage “time is money” is as pertinent to clinical research as to any other corner of the business world. The longer a study drags on, the bigger its price tag becomes. Study timelines can be a source of much anxiety for researchers, creating the markets for time-saving innovations like EDC, eSource, and  risk-based monitoring. Recent trends are not easing this anxiety: a study by Cutting Edge Information finds that early-phase clinical trial budgets increased 157% between 2008 and 2013, with the biggest spike, of $23,600 per patient, occurring in Phase I. Now, several years removed from this time frame, there is evidence these trends are continuing. The study cites a shift toward more complex study protocols in Phase I, a trend still relevant today; as we discussed last month, Bracken Data recently noted an uptick in Phase I patient enrollment, which impacts overall trial cost.